Chemomab Therapeutics Ltd. Shareholders' Equity
Chemomab Therapeutics Ltd. (CMMB) had Shareholders' Equity of $12.33 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-03-23
- 2025-12-31: Stockholders' Equity Attributable to Parent $12.33M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $9.70M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $10.39M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $13.54M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-12-31 | $12.33M 20-F · filed 2026-03-23 | |
| 2025-06-30 | $9.70M 6-K · filed 2025-08-14 | |
| 2025-03-31 | $10.39M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $13.54M 20-F · filed 2026-03-23 | |
| 2024-06-30 | $9.98M 6-K · filed 2025-08-14 | |
| 2024-03-31 | $13.33M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $17.00M 20-F · filed 2026-03-23 | |
| 2023-06-30 | $21.99M 6-K · filed 2024-08-21 | |
| 2023-03-31 | $27.95M 6-K · filed 2024-08-21 | |
| 2022-12-31 | $36.22M 20-F · filed 2026-03-23 | |
| 2022-09-30 | $44.62M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $51.84M 6-K · filed 2023-08-14 | |
| 2022-03-31 | $57.24M 6-K · filed 2023-08-14 | |
| 2021-12-31 | $61.47M 20-F · filed 2025-04-04 | |
| 2021-09-30 | $65.51M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $68.04M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $55.16M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $10.80M 20-F · filed 2024-03-28 | $3.58M 10-K · filed 2021-03-09 |
| 2020-09-30 | $12.16M 10-Q · filed 2021-11-12 | $5.35M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $12.80M 10-Q · filed 2021-11-12 | $8.16M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $10.72M 10-Q · filed 2021-11-12 | $11.56M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $12.37M 10-K · filed 2022-03-30 | $14.91M 10-K · filed 2020-03-17 |
| 2019-09-30 | $20.40M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $27.25M 10-Q · filed 2020-11-16 | $27.27M 10-Q · filed 2020-08-14 |
| 2019-03-31 | $31.34M 10-Q · filed 2020-08-14 | |
| 2018-12-31 | $9.80M 10-K · filed 2021-03-09 | |
| 2017-12-31 | -$609.00K 10-K · filed 2020-03-17 |